BIONEER CORPORATION

Bioneer Signs Exclusive Supply Agreement with Brazil’s Med Solutions Ltda. for CosmeRNA

- Strategic partnership with Med Solutions Ltda., which boasts a network of over 10,000 hospitals

- Minimum purchase commitment of USD 11.34 million over three years

Bioneer announced on the 21st that it has signed a strategic partnership with Med Solutions Ltda., one of Brazil’s leading medical device distributors, to secure an exclusive supply agreement for its next-generation hair care product, CosmeRNA ARI, in Brazil. Under this agreement, Bioneer will supply CosmeRNA through Med Solutions Ltda.’s extensive network of over 10,000 hospitals across Brazil.

The agreement stipulates that Med Solutions Ltda. will maintain its exclusive supply rights by committing to a minimum purchase of USD 11.34 million over three years. To maximize sales performance following the product launch, the company plans to focus on aggressive sales and marketing efforts. This partnership is expected to strengthen Bioneer’s position in the Brazilian hair care market and ensure stable market entry and sustained growth.

Med Solutions Ltda. plays a key role in Brazil’s medical and healthcare industries, having established a strong presence with a nationwide hospital network and reliable products and services. The company is anticipated to play a crucial role in positioning CosmeRNA as an innovative hair loss management solution in Brazil.

The management of Med Solutions Ltda. showed significant interest in CosmeRNA, completing negotiations promptly during a visit to Korea. Both companies are preparing for a large-scale launch of CosmeRNA in Brazil, scheduled for March next year.

The Brazilian hair care market has experienced rapid growth recently, with increasing awareness of hair loss issues among both men and women driving market expansion. According to market research firm Data Bridge, the Brazilian hair loss products market is projected to grow at a compound annual growth rate (CAGR) of 3%, from approximately USD 132 million in 2023 to around USD 149 million by 2027.

Through this agreement, Bioneer plans to introduce its B2B-exclusive product, CosmeRNA Intensive, to the Brazilian market. The product will be launched through hospitals and clinics across Brazil, offering a convenient and effective hair loss management solution for both men and women struggling with hair loss.

A Bioneer representative stated, “We are delighted to bring the innovative value of CosmeRNA to Brazilian customers through this agreement. We will continue to collaborate with companies with strong global customer networks to deliver innovative products faster to markets worldwide.”